In the trial, 20% of patients didn’t respond well to the PCSK9 inhibitor—could genetic markers be used to tailor therapy?

The adverse event in the earlier clinical trial involved amyotrophic lateral sclerosis, which wasn't related to vaccination.

China has reported seven more H9N2 avian flu infections in humans, mostly involving children and all in people whose symptoms ...